With the addition of three experienced physicians to its oncology staff, Metro Health – University of Michigan Health is expanding its capability to treat cancer, an illness expected to be faced by nearly 40 percent of Americans in their lifetimes.
The new staff includes a pioneer in robotic surgery to treat gynecologic cancer, as well as experts in radiation treatment and hematologic disorders.
Cancer is the No. 2 cause of death in the United States, close behind heart disease, according to the federal Centers for Disease Control and Prevention. The National Cancer Institute, another federal agency, estimates 38.4 percent of men and women will be diagnosed with cancer at some point in their lifetime.
“Cancer touches so many lives in West Michigan,” said Laura Smith, Director of Oncology Services for Metro Health. “These additions help us fulfill our commitment to stand alongside our patients, whatever they are going through, by growing capabilities and expertise where our patients need it.”
The new physicians are:
Kevin Brader, MD, a gynecologic oncologist who brings more than a decade of experience in robotic surgery to treat women experiencing cancer of the reproductive organs.
Dr. Brader earned his medical degree at Northwestern University Medical School. He completed his residency in obstetrics and gynecology at the Northwestern University Feinberg School of Medicine and a fellowship in gynecologic oncology at the University of Texas MD Anderson Cancer Center. He is board certified in Gynecologic Oncology.
Sulsal Haque, MD, medical oncologist, specializing in the diagnosis and treatment of oncologic malignancies and the diagnosis and treatment of benign & malignant hematologic disorders.
Dr. Haque earned his medical degree at Leicester Warwick Medical Schools. He completed his residency in internal medicine at University of Cincinnati Medical Center, where he also completed a fellowship in hematology/oncology. He is board certified in Internal Medicine.
Ahmet Tunceroglu, MD, PhD, specializes in radiation oncology, the use of ionizing radiation in the treatment of cancer.
Dr. Tunceroglu earned his medical degree from the University of Medicine and Dentistry of New Jersey, where he also earned a doctorate in biomedical sciences. He completed his residency at the Rutgers University Robert Wood Johnson Medical School. He is board eligible in Radiation Oncology.